ArticleJournal of health, population, and nutrition2026
Association between the oxidative balance score and all-cause mortality in patients with cardiovascular disease-cancer comorbidity.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThe Oxidative Balance Score (OBS) is a composite measure of systemic oxidative stress. This study aims to evaluate the impact of OBS on all-cause mortality in patients with cardiovascular disease-cancer comorbidity and to use machine learning to identify related factors.
methodsWe analyzed data from the 2007-2018 US National Health and Nutrition Examination Survey (NHANES). Cox regression, Kaplan-Meier analysis, restricted cubic splines (RCS), and subgroup analysis were used to explore the association between OBS and CVD-cancer comorbidity. Five machine learning models were constructed and compared to identify the optimal CVD-cancer comorbidity risk prediction model, and feature importance was assessed.
resultsAmong the study participants, compared to participants in the lowest tertile of the OBS score, those in the highest tertile exhibited a lower risk of all-cause mortality (HR = 0.78, 95% CI: 0.64-0.95, p = 0.016). RCS showed that OBS had a no nonlinear evidences with CVD-cancer comorbidity. In subgroup analyses, the association remained consistent across all subgroups, with no statistically significant interaction observed (all P for interaction > 0.05). The random forest algorithm was identified as the optimal predictive model through machine learning evaluation. Decision curve analysis (DCA) and calibration curves further supported the internal validity of the model. SHAP analysis revealed that age, smoking intensity, niacin intake, and selenium levels were the most influential predictive factors.
conclusionsThis study demonstrates a significant inverse association between higher OBS and all-cause mortality in patients with cardiovascular disease-cancer comorbidity and provides an interpretable machine learning model to predict this comorbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.